Official Title
Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
Phase
Phase 4Lead Sponsor
Uppsala UniversityStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Parkinson Disease DyskinesiasStudy Participants
5The purpose of this study is to study different kinds of dyskinesias in advanced Parkinson's disease appearing at different levels of levodopa infusion dose. The hypothesis is that different dyskinesias (dystonia, chorea) correlate to different levels of levodopa concentrations, as detected in plasma.
By using duodenal infusion of levodopa/carbidopa, the plasma concentration of levodopa can be kept fairly constant. Different doses, 10-20% higher or lower than the individually optimized dose will be used. Motor performance is captured by video recordings to be compared to/correlated with plasma levodopa concentrations.
intestinal gel, for continuous daytime infusion
Inclusion Criteria: Clinical diagnosis of idiopathic Parkinson's disease Ongoing treatment with Duodopa Occurrence of dyskinesias, difficult to manage Age 30-90 years Hoehn & Yahr stage 3-5 at worst Exclusion Criteria: Treatment with dopamine agonist or glutamate antagonist Dementia Psychosis Treatment with typical neuroleptics